Status:
UNKNOWN
Conversational Agent Vaccine Promotion RCT
Lead Sponsor:
Northeastern University
Collaborating Sponsors:
Boston University
Boston Medical Center
Conditions:
Pandemics
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to assess the use of and satisfaction with the ECA intervention over a 12-month period, its ability to increase SARS-CoV-2 and influenza vaccination in the BMATP communi...
Detailed Description
4.1.a.1. Randomization. Study participants will be randomized into one of the four study conditions (ENGAGEMENT x TAILORING) using blocked randomization with randomly permuted block sizes of 2 and 4, ...
Eligibility Criteria
Inclusion
- over 18 years old;
- speaks English fluently;
- is able to independently consent;
- has adequate corrected vision to use the ECA system (based on a 1 minute ECA functional screener deployed over the web);
- has adequate hearing to use the ECA system;
- owns a recent model iPhone or Android smartphone.
- do not meet current Boston Public Health commission guidelines for SARS-CoV-2 vaccination OR do not meet current Boston Public Health commission guidelines for Influenza vaccination.
Exclusion
- they are not able demonstrate comprehension of the research study;
- they are unable to use the screener
Key Trial Info
Start Date :
December 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04884750
Start Date
December 12 2022
End Date
December 1 2025
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northeastern University
Boston, Massachusetts, United States, 02115